X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (36) 36
hiv infections - drug therapy (30) 30
index medicus (28) 28
infectious diseases (28) 28
adult (23) 23
female (22) 22
male (22) 22
drug therapy (18) 18
human immunodeficiency virus--hiv (18) 18
antiretroviral drugs (16) 16
hiv (16) 16
middle aged (15) 15
anti-hiv agents - therapeutic use (14) 14
immunology (13) 13
tenofovir (13) 13
adenine - analogs & derivatives (12) 12
hiv infection (12) 12
antiretroviral therapy (11) 11
emtricitabine (10) 10
analysis (9) 9
antiviral agents (9) 9
medicine, general & internal (9) 9
pharmacology & pharmacy (9) 9
adenine - therapeutic use (8) 8
hiv infections - virology (8) 8
microbiology (8) 8
research (8) 8
clinical trials (7) 7
drug resistance, viral (7) 7
drug therapy, combination (7) 7
lamivudine (7) 7
viral load (7) 7
acquired immune deficiency syndrome--aids (6) 6
active antiretroviral therapy (6) 6
adenine - administration & dosage (6) 6
aids/hiv (6) 6
anti-hiv agents - adverse effects (6) 6
anti-retroviral agents - therapeutic use (6) 6
cd4 lymphocyte count (6) 6
deoxycytidine - analogs & derivatives (6) 6
double-blind (6) 6
drug resistance (6) 6
hiv infections - epidemiology (6) 6
hiv-1 (6) 6
infection (6) 6
medicine (6) 6
mutation (6) 6
organophosphonates - therapeutic use (6) 6
pharmacokinetics (6) 6
safety (6) 6
therapy (6) 6
treatment outcome (6) 6
young adult (6) 6
abridged index medicus (5) 5
adenine - adverse effects (5) 5
adults (5) 5
anti-hiv agents - administration & dosage (5) 5
deoxycytidine - therapeutic use (5) 5
drug dosages (5) 5
health aspects (5) 5
highly active antiretroviral therapy (5) 5
hiv-1 - drug effects (5) 5
hiv-1 - genetics (5) 5
infectious disease (5) 5
prevalence (5) 5
protease inhibitors (5) 5
public health (5) 5
ritonavir - administration & dosage (5) 5
tuberculosis (5) 5
adolescent (4) 4
algorithms (4) 4
cohort studies (4) 4
double-blind method (4) 4
drug combinations (4) 4
efavirenz (4) 4
efficacy (4) 4
experiment (4) 4
genotype (4) 4
health economics (4) 4
hiv - genetics (4) 4
hiv-infected patients (4) 4
human-immunodeficiency-virus (4) 4
individuals (4) 4
infections (4) 4
initial treatment (4) 4
organophosphonates - administration & dosage (4) 4
organophosphonates - adverse effects (4) 4
original (4) 4
original research (4) 4
particle physics (4) 4
patients (4) 4
pharmacology (4) 4
research article (4) 4
resource-limited settings (4) 4
transmission (4) 4
usage (4) 4
virus diseases (4) 4
zidovudine (4) 4
adverse events (3) 3
aged (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9987, pp. 2606 - 2615
Summary Background Tenofovir disoproxil fumarate can cause renal and bone toxic effects related to high plasma tenofovir concentrations. Tenofovir alafenamide... 
Internal Medicine | KIDNEY-DISEASE | RATES | MEDICINE, GENERAL & INTERNAL | ABACAVIR-LAMIVUDINE | BONE-MINERAL DENSITY | SAFETY | ADULTS | ANTIRETROVIRAL THERAPY | LOPINAVIR/RITONAVIR | COUNT | EXPOSURE | Humans | Male | Thiazoles - administration & dosage | Carbamates - administration & dosage | Arthralgia - chemically induced | Thiazoles - adverse effects | Sleep Initiation and Maintenance Disorders - chemically induced | Tenofovir | Adenine - adverse effects | Quinolones - adverse effects | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Headache - chemically induced | Emtricitabine | Adenine - analogs & derivatives | Kidney - drug effects | Respiration Disorders - chemically induced | Double-Blind Method | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | HIV Infections - virology | Organophosphonates - adverse effects | Treatment Outcome | CD4 Lymphocyte Count | Nausea | Adenine - administration & dosage | Organophosphonates - administration & dosage | Bone Density - drug effects | Quinolones - administration & dosage | Carbamates - adverse effects | HIV Infections - drug therapy | Viral Load - drug effects | Cobicistat | Deoxycytidine - analogs & derivatives | Drug Combinations | Medical colleges | Clinical trials | Cross infection | Nosocomial infections | HIV (Viruses) | Drug therapy | Health aspects | HIV infection | Analysis | Antiretroviral drugs | Infections | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2011, Volume 11, Issue 5, pp. 363 - 371
Journal Article
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9893, pp. 700 - 708
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2011, Volume 128, Issue 4, pp. 838 - 846.e5
Background In HIV-1–infected patients impaired IFN-γ responses to purified protein derivative (PPD) are associated with an increased risk of active... 
Allergy and Immunology
Journal Article
The Lancet, ISSN 0140-6736, 11/2017, Volume 390, Issue 10107, pp. 2073 - 2082
Journal Article
Journal Article
by Chatrchyan, S and Khachatryan, V and Sirunyan, A.M and Tumasyan, A and Adam, N and Adam, W and Aguilo, E and Bergauer, T and Dragicevic, M and Erö, J and Fabjan, C and Friedl, M and Frühwirth, R and Ghete, V.M and Hammer, J and Hoch, M and Hörmann, N and Hrubec, J and Jeitler, M and Kiesenhofer, W and Knünz, V and Krammer, M and Krätschmer, I and Liko, D and Majerotto, W and Mikulec, I and Pernicka, M and Rahbaran, B and Rohringer, H and Rohringer, C and Schöfbeck, R and Strauss, J and Szoncsó, F and Taurok, A and Waltenberger, W and Walzel, G and Widl, E and Wulz, C.-E and Chekhovsky, V and Emeliantchik, I and Litomin, A and Makarenko, V and Mossolov, V and Shumeiko, N and Solin, A and Stefanovitch, R and Suarez Gonzalez, J and Fedorov, A and Korzhik, M and Missevitch, O and Zuyeuski, R and Bansal, M and Bansal, S and Beaumont, W and Cornelis, T and De Wolf, E.A and Druzhkin, D and Janssen, X and Luyckx, S and Mucibello, L and Ochesanu, S and Roland, B and Roland, C and Roland, G and Rougny, R and Selvaggi, G and Selvaggi, M and Staykova, Z and Van Haevermaet, H and Van Mechelen, P and Van Remortel, N and Van Spilbeeck, A and Blekman, F and Blyweert, S and DʼHondt, J and Devroede, O and Gonzalez Suarez, R and Goorens, R and Kalogeropoulos, A and Maes, M and Olbrechts, A and Tavernier, S and Van Doninck, W and Van Lancker, L and Van Mulders, P and Van Onsem, G.P and Villella, I and Clerbaux, B and De Lentdecker, G and Dero, V and Dewulf, J.P and Gay, A.P.R and Hreus, T and Léonard, A and Marage, P.E and Mohammadi, A and Reis, T and Rugovac, S and Thomas, S and Thomas, M and ... and CMS Collaboration and Los Alamos National Lab. (LANL), Los Alamos, NM (United States) and Argonne National Lab. (ANL), Argonne, IL (United States) and Fermi National Accelerator Lab. (FNAL), Batavia, IL (United States) and Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States)
Physics Letters B, ISSN 0370-2693, 09/2012, Volume 716, Issue 1, pp. 30 - 61
Journal Article